Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Kraft Heinz, NotCo create JV for AI-driven plant-based innovation The Kraft Heinz Company has created a joint venture (JV) with Chilean food tech start-up TheNotCompany (NotCo) for… bySrinathFebruary 27, 2022
